Product Detail


Share to:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

CAS No. 1374248-77-7, Ubrogepant

  • 1374248-77-7

  • C29H26F3N5O3

  • 549.54

  • 1.45±0.1

  • 98.0% min (HPLC/GC)

  • white crystalline powder / Colorless clear liquid

  • Migraine

  • Ubrogepant

  • 12/22/2041 (Ubrogepant)

  • CGRP

  • N

  • 2022

  • ISO 9001



As an oral calcitonin gene-related peptide (CGRP) receptor antagonist, Ubrogepant offers fast-acting, effective relief for acute migraines without the typical adverse effects of triptans. This novel approach paves the way for a new era in migraine management, providing patients with a much-needed alternative. By incorporating Ubrogepant into your pharmaceutical portfolio, you can make a significant impact on improving the lives of migraine sufferers and advance neurological care.